iwCLL 2013: Dr. John Byrd Discusses the Role o... - CLL Support

CLL Support

22,510 members38,657 posts

iwCLL 2013: Dr. John Byrd Discusses the Role of Novel Therapies versus Standard Chemo-Immunotherapy

bkoffman profile image
bkoffmanCLL CURE Hero
4 Replies

Hi friends,

I am off to ASH with my slowly improving cough and runny nose. Expect updates on the fly on the latest CLL news.

In the meantime my blog bkoffman.blogspot.com will give you something to cogitate. Can't get enough opinions on this important topic of chemo versus novel therapies.

Stay strong

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Ernest2 profile image
Ernest2

That's great news to hear you are now well enough to travel to ASH Brian, and wish you a continued recovery.

Saw my consultant team yesterday, and I was pleasantly surprised that the thinking seemed to have dramatically changed from previous visit (re FCR vs new therapies), and their answer to most of the difficult Q I asked was the new therapies.

They may not be perfect yet, but are hopefully a big step forward that we have to try out.

On the MRD front I think I could happily learn to live with my CLL, just need to keep it under control at a healthy level.

Look forward to the posts

Ernest

jangreen profile image
jangreen

Hi I watch all these videos because I find them so informative. I went to a cll meeting at Bart's London but nothing was videoed so nothing is on the net to share. How difficult is it to set up these videos? I know that cll uk has limited resources but is it possible? I don't think we can do a professional job like yourself but I don't think that matters. If you have any suggestions about how to get started please let us know. Many thanks

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin in reply to jangreen

Hi Jangreen it was great to meet again very briefly in London on Tuesday.

You will be pleased to learn about developing colaborative initiatives between CLLSA and partner organisations to produce material with a UK and European perspective. For hosting here and on the CLLSA website. I am pleased to announce we are moving forward with a more active collaboration and alliance with Andrew Schorr and Patient Power. Partners page beta.patientpower.info/chro...

Short term CLLSA and Patient Power have designed a few new video players to make available groupings of different types of video as they come available from variouse venues:one for Living with CLL, one for UK & European Perspectives, one for Global Perspectives. We will also be creating material from interviews with patients and carers these are in planning for the UK. This all takes time but is underway.

We will not be videoing patient meetings or speakers talks. But hope to be able to interview selected patients, advocates, health professionals and clinicians at these events.to create relevant educational material in the future. at the moment Andrew is at ASH with Brian and others interviewing selected people to provide a variety of perspectives from those attending Ash.

I hope this is helpful

Nick. ,

bkoffman profile image
bkoffmanCLL CURE Hero in reply to HAIRBEAR_UK

Let me know how I can help with the videos.

You may also like...

iwCLL 2013: Dr. Sharman discusses why we feel so lousy, and much more.

go on from there. Please seem my blog: http://bkoffman.blogspot.com Parts 5-7 will follow in...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

another interview from ASH 2013 that I just posted on my blog http://bkoffman.blogspot.com , Dr....

EHA 2019: Dr. Maloney on CAR-T and Dr. Davids of Chemo-Immunotherapy combinations

about the role of chemo-immunotherapy (CIT) in CLL. Dana Farber (DFCI) is one of the CLL Meccas...

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

on my blog: http://bkoffman.blogspot.com Stay strong. We are all in this together. Brian...

Additional drugs stopped. Is this other peoples experience.